Edgestream Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Edgestream Partners’s Portfolio RARE Stock Details RARE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.3M	Buy
2023 Q2	–	Sell
2023 Q1	$267K	Buy
2022 Q4	–	Sell
2022 Q3	$709K	Buy